Tagged with EG

healthcare In the past, the Moroccan pharmaceutical sector primarily served local needs. Now it is ramping up its research and development capabilities, looking outwards to global markets, developing partnerships with other African countries, and beginning to think about social programs such as public access to healthcare. “[Morocco’s] success grew from a…

strategic levels Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also describes how the company’s new reagent facility in Germany will help bolster it domestically and regionally. Can you tell us…

regulation Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey, the evolution of the legal landscape and her expectations for the industry’s future. With pricing and regulations as the major challenges facing players within the Turkish pharma and…

Steri-Tech Steri-Tech is one of the few local contract sterilization service providers available in Puerto Rico. Jorge and Andy Vivoni, president and business development manager, discuss how they ensure that pharmaceutical companies continue to establish themselves in Puerto Rico. What is the strategic importance of Steri-Tech within the Puerto Rican life sciences…

legal A founding partner of YükselKarkınKüçük, Gökhan Gökçe discusses the firm’s involvement with several high profile cases concerning the healthcare and life science sector’s reference pricing system, and also elaborates on the strategic trends in different types of operating structures as a result of shifting dynamics faced by the broader Turkish…

medical devices The industry of medical devices is soaring in Mexico. The general manager of ConvaTec discusses strategic priorities, new approaches and how reduced time to market is feeding the double-digit growth of the company The last time we met you was back in 2012. What kept you busy over the past…

government Ana Ríus became the Secretary of Health of Puerto Rico in 2013 following a very dynamic career as Head of the Puerto Rico Health Medical Services Administration. She discusses the current changes being made in the country’s health system and how Medicare Advantage funding is critical to maintaining a stable…

insurance Jim O’Drobinak came to Puerto Rico at the end of 2011, following a career largely based in Florida, to run Medical Card System (MCS), a major insurance provider on the island. He shares his experiences and challenges to ensure a functioning health system in a time of doubt regarding healthcare…

vaccines BioNet’s CEO, Pham Hong Thai, shares his thoughts on BioNet’s new vaccine that will be launched in the coming year, his belief in Thailand as a research and clinical trials center, and the growth plans for BioNet over the coming years. What drove you to co-found the company and how…

innovation The chairman for the National Innovation Agency (NIA), Mr. Somchet Thinapong, shares his personal ambitions to bring innovation to the forefront of Thailand’s agenda, why innovation is vital to ensuring the success of the nation and where he hopes to see Thailand’s innovation strategy in the coming years. What experiences…

consultancy Prevention versus remediation is the name of the game in regulatory and compliance issues for pharmaceutical manufacturers; the cost of non-compliance is much higher than investing proactively in compliance. Elizabeth Plaza, founder and chairwoman of the board of Puerto Rican-based regulatory and compliance consultancy Pharma-Bio Serv, discusses how her company…

IMS IMS Health recently released its World Review 2015. The new general manager of North Latin America shares the company’s assessment on the performance of the Mexican pharmaceutical market for 2014, what trends are shaping the industry as well as the moderate, yet positive outlook for 2015. How would you assess…